Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN). The post Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today? appeared first on InvestorPlace . More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.